Researchers analyzed the gut microbiota to study the differences in its composition among patients with Henoch-Schönlein purpura nephritis vs healthy individuals.
The effect of cholecalciferol supplementation on parathyroid hormone levels and bone loss at the lumbar spine in kidney transplant recipients was studied in a placebo-controlled trial.
Infection-related mortality appears worse for patients with lupus nephritis.
Investigators report findings from the PROTECT study assessing the efficacy and safety of pegloticase for uncontrolled gout among kidney transplant recipients.
Some 15% of patients receiving dialysis in the United States have a gout diagnosis, according to a recent study.
Investigators found a 27% decreased risk of kidney adverse events in a study of patients with normal kidney function or mild-to-moderate chronic kidney disease.
The management recommendations for lupus nephritis are poised to change significantly in the coming months, a KDIGO committee revealed.
The current guideline-recommended creatinine-based eGFR equation incorporates a race coefficient that may overestimate eGFR in Black adults and contribute to discordant care.
Investigators examined the urate-lowering effects of febuxostat, allopurinol, and benzbromarone and their association with renal protection in CKD.
Among children on dialysis, those with lupus nephritis were more likely to be hospitalized.
